openPR Logo
Press release

Overview on Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing

Overview on Evolving Pharmaceutical Marketing Strategies:

ResearchMoz added Latest Research Report titled " Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing " to it's Large Report database.

GBI Research’s latest report,""Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing"" provides a comprehensive analysis of the changing pharmaceutical marketing landscape in the digital age.

While the pharmaceutical industry readily adopts new technologies to provide medical advancements, it has been much slower to adopt technology within its marketing efforts, mostly relying on traditional channels and methods. However, the decreasing effectiveness of these traditional channels, given changing physician, patient and consumer trends in today’s increasingly digital society, is forcing an evolution of pharmaceutical marketing strategies. The report examines how the effective implementation of various digital marketing approaches, in conjunction with traditional channels in an integrated multichannel marketing strategy, has the ability to expand marketing reach, increase audience engagement, provide higher return on investment (ROI) and improve methods of tracking ROI for pharmaceutical companies.

Request for Sample PDF of Premium Research Report with TOC: https://www.researchmoz.us/enquiry.php?type=S&repid=998992

The report features an overview of the various marketing channels available to pharma, and examines the factors driving change within this field. It analyzes how a wide range of digital marketing methods can be effectively integrated into a synergistic multichannel marketing strategy that allows both traditional and newer channels to complement each other. Analysis of the main challenges and risks associated with digital marketing methods, in addition to potential solutions and approaches to overcoming them, is provided. Real-world case studies of marketing strategies and campaigns employed by pharma are also included.

GBI Research conducted extensive research in order to provide a comprehensive view of the evolving pharmaceutical marketing landscape. In addition to garnering views from internal experts GBI Research conducted an extensive interview with pharmaphorum CEO and founder Paul Tunnah, who is an experienced industry thought leader and advisor with a specialist focus on cross-stakeholder communication, digital/social media engagement and collaborative innovation. Based on the totality of our research, strategic recommendations and guidelines are provided throughout the report for the effective implementation of digital marketing strategies within a coherent overall multichannel marketing strategy.

Browse more details @ https://www.researchmoz.us/evolving-pharmaceutical-marketing-strategies-digital-as-a-key-component-of-multichannel-marketing-report.html

Table of contents

Introduction
Executive Summary
Overview of Marketing Channels Available to Pharma
Drivers of Change in Pharma Marketing Strategy
Evolving Patient and Consumer Market Trends
Evolving Physician Market Trends
Paradigm Shifts in Pharma Sales Force
Advantages of Digital Strategies versus Traditional Marketing Strategies in Pharma
Evolving Market Access Strategies
Digital and Multichannel Marketing Strategies
Multichannel Marketing
Implementing a Multichannel Marketing Strategy
Implementing Digital into Face-to-Face Detailing
eDetailing
Big Data for Pharma Marketing
Predictive Modeling: Fundamental Source of Big Data’s Power
Using Big Data for Physician Targeting
Using Big Data for Sales Force Allocation
Social Media: Key Opportunities Provided by this Channel
Social Media Marketing: Key Points to Note
Social Media Marketing Case Study
Embracing Video Content for Digital Pharma Marketing
Key Features of Effective Video Marketing
Prepare for Digital Drug Launches
Mobile Marketing: Updating Practices for the Smartphone Era
Pharma Mobile Apps

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://deep-research-report.blogspot.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Overview on Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing here

News-ID: 743714 • Views:

More Releases from Evolving Pharmaceutical Marketing Strategies

Advanced Technologies| Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing
Advanced Technologies| Evolving Pharmaceutical Marketing Strategies: Digital as …
Researchmoz added Most up-to-date research on "Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing" to its huge collection of research reports. GBI Research’s latest report,""Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing"" provides a comprehensive analysis of the changing pharmaceutical marketing landscape in the digital age. To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=998992 While the pharmaceutical industry readily adopts new technologies to provide

More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the